Confluent and reticulated papillomatosis of Gougerot and Carteaud is an uncommon but distinctive acquired ichthyosiform dermatosis characterized by persistent dark, scaly, papules and plaques that tend to be localized predominantly on the central trunk.
☆ AI Dermatology — Free Service Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Confluent and reticulated papillomatosis (CRP), ikwabizwa ngokuba yi-Gougerot-Carteaud syndrome, iziphumo zokukhula kweeseli zolusu okungaqhelekanga. Ibonakala njengamachokoza amnyama angenantlungu anokudibana abe ngamabala amakhulu, adla ngokuvela kumantla esifuba nasentanyeni yabantu abancinci kunye nabantu abadala abasencane. Ukhetho lokuqala lonyango luyi-minocycline. Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
I-CRP (Confluent reticulated papillomatosis) idla ngokubonakala njengamabala amnyama kunye neepatch ezihlala ngaphandle kwempawu, ezisuka esuswini olujikeleze intamo, iintamo, isifuba esiphezulu, kunye nomqolo ophezulu. Ngamanye amaxesha, kunokusasazeka phezulu ebusweni (forehead) kunye phantsi kwindawo ye-pubic. Amayeza okubulala iintsholongwane afana ne minocycline abe lolona khetho lukhethwayo lonyango. CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ Unyango
#Minocycline